Spotlight: Event Recap from 2021 DEI Report

NOTE: On December 8th, Big4Bio:Philadelphia sponsor Life Sciences Pennsylvania (LSPA) conducted a virtual leadership panel with representatives from three different industries to discuss their culture, hiring practices, and managing the changing landscape of the workforce. Part 1 of a transcript recap of this event is included in our just-published 2021 DEI Report; part 2 continues […]

Read More

Spotlight: The Biotech Showcase Returns to San Francisco as a Hybrid Event

The Big4Bio Podcast · The Biotech Showcase Returns to San Francisco as a Hybrid Event BioWeekSF (aka “JPM” or “JPM Week”) is the second week in January in SF that kicks off the new year in industry dealmaking/partnering. We call it “BioWeekSF” as there are many additional, important events that go on outside and beyond […]

Read More

Spotlight: Quintara Discovery — A CRO Where No Project is Too Big or Too Small

Marie Daghlian Quintara Discovery, Inc prides itself for being a flexible partner in biotech companies’ drug discovery and development efforts. Based in the San Francisco Bay Area, it provides high-quality drug discovery services to the vibrant biotech community in the region and beyond, including in vitro ADME profiling, bioanalysis services, and dedicated assay development and […]

Read More

Spotlight: Quintara Discovery — A CRO Where No Project is Too Big or Too Small

Marie Daghlian Quintara Discovery, Inc prides itself for being a flexible partner in biotech companies’ drug discovery and development efforts. Based in the San Francisco Bay Area, it provides high-quality drug discovery services to the vibrant biotech community in the region and beyond, including in vitro ADME profiling, bioanalysis services, and dedicated assay development and […]

Read More

Spotlight: Quintara Discovery — A CRO Where No Project is Too Big or Too Small

Marie Daghlian Quintara Discovery, Inc prides itself for being a flexible partner in biotech companies’ drug discovery and development efforts. Based in the San Francisco Bay Area, it provides high-quality drug discovery services to the vibrant biotech community in the region and beyond, including in vitro ADME profiling, bioanalysis services, and dedicated assay development and […]

Read More

Spotlight: Quintara Discovery — A CRO Where No Project is Too Big or Too Small

Marie Daghlian Quintara Discovery, Inc prides itself for being a flexible partner in biotech companies’ drug discovery and development efforts. Based in the San Francisco Bay Area, it provides high-quality drug discovery services to the vibrant biotech community in the region and beyond, including in vitro ADME profiling, bioanalysis services, and dedicated assay development and […]

Read More

Spotlight: The 2021 Life Sciences Workforce Trends Report for California

Big4Bio sponsors Biocom and CLS have published a joint report, “2021 Life Sciences Workforce Trends,” which includes the most pressing current and projected talent needs of California’s life sciences industry, a constantly-leading driver of employment across the state. The three foundational datasets described, include the number of job postings from January 2017 to December 2020, […]

Read More

Priming to Launch “Oligos as a Service”

In the final feature on Molecular Assemblies, Big4Bio spoke with Stephen Bates, vice president of sales and marketing, about the year ahead for the company as it prepares to commercialize its synthetic DNAs. Companies to Watch – Molecular Assemblies by Marie Daghlian Stephen Bates has come full circle in a long career in sales and […]

Read More

Podcast: The Write Stuff — Reinventing the Synthesis of DNA With Enzymes

Companies to Watch – Molecular Assemblies The Big4Bio Podcast · The Write Stuff: Reinventing the Synthesis of DNA with Enzymes Molecular Assemblies’ President and CEO Mike Kamdar and Co-Founder and Chief Scientific Officer Bill Efcavitch talk more about the company’s enzymatic synthesis of DNA and its plans for commercialization.   NEXT WEEK: Q&A with Molecular […]

Read More

Spotlight Q&A with Stephen Ghiglieri, Danforth Advisors

Stephen Ghiglieri is a veteran corporate officer of life science companies and a newly-appointed Managing Director of the Western Region for Danforth Advisors Big4Bio:  As an experienced finance and operations executive, what attracted you to the life sciences? SG: I have spent the majority of my career in life sciences, but it was a departure […]

Read More

Moving Synthetic Biology Into the 21st Century

In the second of four features on Molecular Assemblies, based on a conversation with CEO and President Mike Kamdar and Co-founder and Chief Scientific Officer Bill Efcavitch, Big4Bio takes a deeper look at the company’s enzymatic DNA synthesis technology, why it is needed, and the markets it serves. Companies to Watch – Molecular Assemblies by […]

Read More

Changing the Paradigm for Writing DNA

In the first of four features on Molecular Assemblies, Big4Bio spoke with CEO and President Mike Kamdar and Co-founder and Chief Scientific Officer Bill Efcavitch about how the company got started, their technology for synthesizing DNA and why it is better than current methods, and their plans moving forward. The second feature will provide an […]

Read More

Spotlight: Explora BioLabs

Leading the Nation’s Preclinical Vivarium Market Explora BioLabs provides preclinical, AAALAC-accredited vivarium space and related services to biotech clients in development stages from early startup to maturity. With nearly 200,000 square feet of space across 18 locations in biotech-dense communities, the company prides itself on providing clients the ability to initiate preclinical in vivo programs […]

Read More

The Big4Bio Company to Watch Program
September 2021: Molecular Assemblies

THE COMPANY/THE MISSION Changing the Paradigm for Writing DNA Molecular Assemblies’ leaders detail how the company got started, the company’s technology for synthesizing DNA, and why that technology is better than current methods.     THE TECHNOLOGY, PART 1 Moving Synthetic Biology into the 21st Century A deeper look at the company’s enzymatic DNA synthesis […]

Read More